The association of stage 1 hypertension defined by the 2017 ACC/AHA hypertension guideline and subsequent cardiovascular events among adults <50 years

被引:0
|
作者
Sitong Liu
Yali Wang
Yanxia Xie
Jia Zheng
Rongrong Guo
Yue Dai
Zhaoqing Sun
Liying Xing
Xingang Zhang
Yingxian Sun
Liqiang Zheng
机构
[1] Shengjing Hospital of China Medical University,Department of Clinical Epidemiology, Library
[2] Shengjing Hospital of China Medical University,Department of Cardiology
[3] Liaoning Provincial Center for Disease Control and Prevention,Institute of Chronic Disease
[4] The First Affiliated Hospital of China Medical University,Department of Cardiology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
This study was performed to investigate the association between stage 1 hypertension defined by the 2017 ACC/AHA guidelines and the risk of adverse events among adults aged 35 to 49 years. A total of 20,072 adults aged 35–49 years, without a history of cardiovascular disease (CVD) at baseline were included in the present study. Adjusted Cox proportional hazards models were applied to estimate hazard ratios (HRs) with 95% confidence intervals (CIs). During a median follow-up period of 12.5 years, the results indicated that 777 subjects suffered all-cause death and 299 subjects developed CVD. A total of 830 subjects were involved in incident stroke and 141 subjects had a myocardial infarction (MI). Stage 1 hypertension had a HR (95% CI) of 1.38 (1.13–1.70) for all-cause mortality, 1.74 (1.20–2.53) for CVD mortality, 1.78 for (1.40–2.26) for stroke incidence, and 1.64 (0.99–2.71) for MI incidence, respectively, compared with blood pressure (BP) <120/<80 mmHg. The results show that after adjusting for sex, age, and other potential CVD factors, the incidence of stroke was the only parameter significantly associated with stage 1 hypertension (HR and 95% CI: 1.53, 1.20–1.95). Stage 1 hypertension defined by the 2017 ACC/AHA guidelines was associated with an increased risk of stroke among adults aged 35 to 49 years in rural areas of China.
引用
收藏
页码:233 / 240
页数:7
相关论文
共 50 条
  • [31] Impact of the 2017 AHA/ACC hypertension guideline on hypertension prevalence and cardiovascular risk factors in a healthy older cohort
    Chowdhury, E. K.
    Nelson, M. R.
    Ernst, M. E.
    Margolis, K. L.
    Beilin, L. J.
    Johnston, C. I.
    Murray, A. M.
    Woods, R. L.
    Wolfe, R.
    Tonkin, A. M.
    Williamson, J. D.
    Stocks, N. P.
    McNeil, J.
    Reid, C.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3964 - 3964
  • [32] Hypertension Defined by 2017 ACC/AHA Guideline, Ideal Cardiovascular Health Metrics, and Risk of Cardiovascular Disease: A Nationwide Prospective Cohort Study
    Wu, Shujing
    Xu, Yu
    Zheng, Ruizhi
    Lu, Jieli
    Li, Mian
    Chen, Li
    Huo, Yanan
    Xu, Min
    Wang, Tiange
    Zhao, Zhiyun
    Wang, Shuangyuan
    Lin, Hong
    Dai, Meng
    Zhang, Di
    Niu, Jingya
    Qin, Guijun
    Yan, Li
    Wan, Qin
    Chen, Lulu
    Shi, Lixin
    Hu, Ruying
    Tang, Xulei
    Su, Qing
    Yu, Xuefeng
    Qin, Yingfen
    Chen, Gang
    Gao, Zhengnan
    Wang, Guixia
    Shen, Feixia
    Luo, Zuojie
    Chen, Yuhong
    Zhang, Yinfei
    Liu, Chao
    Wang, Youmin
    Wu, Shengli
    Yang, Tao
    Li, Qiang
    Mu, Yiming
    Zhao, Jiajun
    Bi, Yufang
    Wang, Weiqing
    Ning, Guang
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2022, 20
  • [33] The contribution of the systolic and diastolic components for the diagnosis of arterial hypertension under the 2017 ACC/AHA Guideline and metabolic heterogeneity among individuals with Stage 1 hypertension
    Cesena, Fernando H. Y.
    Nary, Fernando C.
    Santos, Raul D.
    Bittencourt, Marcio S.
    JOURNAL OF CLINICAL HYPERTENSION, 2020, 22 (07): : 1192 - 1199
  • [34] Changes in the prevalence of measures associated with hypertension among Iranian adults according to classification by ACC/AHA guideline 2017
    Mirzaei, Mohsen
    Mirzaei, Masoud
    Mirzaei, Mojtaba
    Bagheri, Behnam
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [35] Changes in the prevalence of measures associated with hypertension among Iranian adults according to classification by ACC/AHA guideline 2017
    Mohsen Mirzaei
    Masoud Mirzaei
    Mojtaba Mirzaei
    Behnam Bagheri
    BMC Cardiovascular Disorders, 20
  • [36] Hypertension Defined by 2017 ACC/AHA Guideline, Ideal Cardiovascular Health Metrics, and Risk of Cardiovascular Disease: A Nationwide Prospective Cohort Study
    Wu, Shujing
    Xu, Yu
    Zheng, Ruizhi
    Lu, Jieli
    Li, Mian
    Chen, Li
    Huo, Yanan
    Xu, Min
    Wang, Tiange
    Zhao, Zhiyun
    Wang, Shuangyuan
    Lin, Hong
    Dai, Meng
    Zhang, Di
    Niu, Jingya
    Qin, Guijun
    Yan, Li
    Wan, Qin
    Chen, Lulu
    Shi, Lixin
    Hu, Ruying
    Tang, Xulei
    Su, Qing
    Yu, Xuefeng
    Qin, Yingfen
    Chen, Gang
    Gao, Zhengnan
    Wang, Guixia
    Shen, Feixia
    Luo, Zuojie
    Chen, Yuhong
    Zhang, Yinfei
    Liu, Chao
    Wang, Youmin
    Wu, Shengli
    Yang, Tao
    Li, Qiang
    Mu, Yiming
    Zhao, Jiajun
    Bi, Yufang
    Wang, Weiqing
    Ning, Guang
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2022, 20
  • [37] Comparison of the 2017 ACC/AHA Hypertension Guideline with Earlier Guidelines on Estimated Reductions in Cardiovascular Disease
    Bundy, Joshua D.
    Mills, Katherine T.
    He, Jiang
    CURRENT HYPERTENSION REPORTS, 2019, 21 (10)
  • [38] Comparison of the 2017 ACC/AHA Hypertension Guideline with Earlier Guidelines on Estimated Reductions in Cardiovascular Disease
    Joshua D. Bundy
    Katherine T. Mills
    Jiang He
    Current Hypertension Reports, 2019, 21
  • [39] Implications of the 2017 ACC/AHA Hypertension Guideline for Public Health in Nepal
    Watkins, David A.
    JAMA NETWORK OPEN, 2018, 1 (03)
  • [40] Comparison of the association of masked hypertension defined by the 2017 ACC/AHA BP guideline versus the JNC7 guideline with left ventricular hypertrophy
    Poudel, Bharat
    Viera, Anthony J.
    Shimbo, Daichi
    Schwartz, Joseph E.
    Shikany, James M.
    Sakhuja, Swati
    Lloyd-Jones, Donald M.
    Muntner, Paul
    Yano, Yuichiro
    JOURNAL OF HYPERTENSION, 2022, 40 (08) : 1597 - 1606